FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy

Macrophages contribute to tumour progression and response to therapy. Here, the authors show that absence of FGF2 in the tumour microenvironment reduces tumour growth and enhances the anti-tumour immune response by altering macrophage polarization. As a result, disruption of this macrophage programm...

Full description

Bibliographic Details
Main Authors: Jae Hong Im, Jon N. Buzzelli, Keaton Jones, Fanny Franchini, Alex Gordon-Weeks, Bostjan Markelc, Jianzhou Chen, Jin Kim, Yunhong Cao, Ruth J. Muschel
Format: Article
Language:English
Published: Nature Portfolio 2020-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-17914-x
_version_ 1818894465270546432
author Jae Hong Im
Jon N. Buzzelli
Keaton Jones
Fanny Franchini
Alex Gordon-Weeks
Bostjan Markelc
Jianzhou Chen
Jin Kim
Yunhong Cao
Ruth J. Muschel
author_facet Jae Hong Im
Jon N. Buzzelli
Keaton Jones
Fanny Franchini
Alex Gordon-Weeks
Bostjan Markelc
Jianzhou Chen
Jin Kim
Yunhong Cao
Ruth J. Muschel
author_sort Jae Hong Im
collection DOAJ
description Macrophages contribute to tumour progression and response to therapy. Here, the authors show that absence of FGF2 in the tumour microenvironment reduces tumour growth and enhances the anti-tumour immune response by altering macrophage polarization. As a result, disruption of this macrophage programming by anti-FGF2 blocking antibodies enhances the outcome from radiotherapy.
first_indexed 2024-12-19T18:28:55Z
format Article
id doaj.art-aac2c94a42384be185bf6c4fce5f6dff
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-19T18:28:55Z
publishDate 2020-08-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-aac2c94a42384be185bf6c4fce5f6dff2022-12-21T20:10:47ZengNature PortfolioNature Communications2041-17232020-08-0111111410.1038/s41467-020-17914-xFGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapyJae Hong Im0Jon N. Buzzelli1Keaton Jones2Fanny Franchini3Alex Gordon-Weeks4Bostjan Markelc5Jianzhou Chen6Jin Kim7Yunhong Cao8Ruth J. Muschel9Oxford Institute for Radiation Oncology, University of OxfordOxford Institute for Radiation Oncology, University of OxfordOxford Institute for Radiation Oncology, University of OxfordThe Kennedy Institute of RheumatologyNuffield Department of Surgical Sciences, University of OxfordOxford Institute for Radiation Oncology, University of OxfordOxford Institute for Radiation Oncology, University of OxfordGalaxy BiotechOxford Institute for Radiation Oncology, University of OxfordOxford Institute for Radiation Oncology, University of OxfordMacrophages contribute to tumour progression and response to therapy. Here, the authors show that absence of FGF2 in the tumour microenvironment reduces tumour growth and enhances the anti-tumour immune response by altering macrophage polarization. As a result, disruption of this macrophage programming by anti-FGF2 blocking antibodies enhances the outcome from radiotherapy.https://doi.org/10.1038/s41467-020-17914-x
spellingShingle Jae Hong Im
Jon N. Buzzelli
Keaton Jones
Fanny Franchini
Alex Gordon-Weeks
Bostjan Markelc
Jianzhou Chen
Jin Kim
Yunhong Cao
Ruth J. Muschel
FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
Nature Communications
title FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
title_full FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
title_fullStr FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
title_full_unstemmed FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
title_short FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
title_sort fgf2 alters macrophage polarization tumour immunity and growth and can be targeted during radiotherapy
url https://doi.org/10.1038/s41467-020-17914-x
work_keys_str_mv AT jaehongim fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT jonnbuzzelli fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT keatonjones fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT fannyfranchini fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT alexgordonweeks fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT bostjanmarkelc fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT jianzhouchen fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT jinkim fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT yunhongcao fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy
AT ruthjmuschel fgf2altersmacrophagepolarizationtumourimmunityandgrowthandcanbetargetedduringradiotherapy